Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial
Titel:
Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial
Auteur:
Cramer, Paula von Tresckow, Julia Bahlo, Jasmin Robrecht, Sandra Langerbeins, Petra Al-Sawaf, Othman Engelke, Anja Fink, Anna-Maria Fischer, Kirsten Tausch, Eugen Seiler, Till Fischer von Weikersthal, Ludwig Hebart, Holger Kreuzer, Karl-Anton Böttcher, Sebastian Ritgen, Matthias Kneba, Michael Wendtner, Clemens-Martin Stilgenbauer, Stephan Eichhorst, Barbara Hallek, Michael